Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !

Metropolis Healthcare Management

Management Kriterienprüfungen 1/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Surendran Chemmenkotil

Geschäftsführender

₹52.3m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts23.9%
Amtszeit als Geschäftsführer1.4yrs
Eigentum des Geschäftsführersn/a
Durchschnittliche Amtszeit des Managements1.4yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder4.9yrs

Jüngste Management Updates

Recent updates

Metropolis Healthcare Limited Just Missed EPS By 5.7%: Here's What Analysts Think Will Happen Next

May 24
Metropolis Healthcare Limited Just Missed EPS By 5.7%: Here's What Analysts Think Will Happen Next

Why Investors Shouldn't Be Surprised By Metropolis Healthcare Limited's (NSE:METROPOLIS) P/E

Mar 28
Why Investors Shouldn't Be Surprised By Metropolis Healthcare Limited's (NSE:METROPOLIS) P/E

Capital Allocation Trends At Metropolis Healthcare (NSE:METROPOLIS) Aren't Ideal

Jan 13
Capital Allocation Trends At Metropolis Healthcare (NSE:METROPOLIS) Aren't Ideal

Metropolis Healthcare Limited's (NSE:METROPOLIS) Share Price Matching Investor Opinion

Dec 23
Metropolis Healthcare Limited's (NSE:METROPOLIS) Share Price Matching Investor Opinion

Does Metropolis Healthcare (NSE:METROPOLIS) Have A Healthy Balance Sheet?

Sep 08
Does Metropolis Healthcare (NSE:METROPOLIS) Have A Healthy Balance Sheet?

Metropolis Healthcare (NSE:METROPOLIS) Could Be Struggling To Allocate Capital

Jun 20
Metropolis Healthcare (NSE:METROPOLIS) Could Be Struggling To Allocate Capital

Metropolis Healthcare (NSE:METROPOLIS) Might Be Having Difficulty Using Its Capital Effectively

Mar 14
Metropolis Healthcare (NSE:METROPOLIS) Might Be Having Difficulty Using Its Capital Effectively

Metropolis Healthcare's (NSE:METROPOLIS) Dividend Will Be ₹8.00

Feb 13
Metropolis Healthcare's (NSE:METROPOLIS) Dividend Will Be ₹8.00

Metropolis Healthcare Limited's (NSE:METROPOLIS) Intrinsic Value Is Potentially 25% Below Its Share Price

Sep 25
Metropolis Healthcare Limited's (NSE:METROPOLIS) Intrinsic Value Is Potentially 25% Below Its Share Price

Is Metropolis Healthcare (NSE:METROPOLIS) A Risky Investment?

Sep 10
Is Metropolis Healthcare (NSE:METROPOLIS) A Risky Investment?

Metropolis Healthcare (NSE:METROPOLIS) Has A Rock Solid Balance Sheet

Jun 07
Metropolis Healthcare (NSE:METROPOLIS) Has A Rock Solid Balance Sheet

Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future

May 16
Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future

Is Now The Time To Put Metropolis Healthcare (NSE:METROPOLIS) On Your Watchlist?

Mar 17
Is Now The Time To Put Metropolis Healthcare (NSE:METROPOLIS) On Your Watchlist?

Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future

Jan 29
Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future

Do Metropolis Healthcare's (NSE:METROPOLIS) Earnings Warrant Your Attention?

Dec 14
Do Metropolis Healthcare's (NSE:METROPOLIS) Earnings Warrant Your Attention?

Metropolis Healthcare (NSE:METROPOLIS) Looks To Prolong Its Impressive Returns

Oct 12
Metropolis Healthcare (NSE:METROPOLIS) Looks To Prolong Its Impressive Returns

Should You Be Adding Metropolis Healthcare (NSE:METROPOLIS) To Your Watchlist Today?

Aug 27
Should You Be Adding Metropolis Healthcare (NSE:METROPOLIS) To Your Watchlist Today?

Here's What Metropolis Healthcare's (NSE:METROPOLIS) Strong Returns On Capital Mean

Jul 06
Here's What Metropolis Healthcare's (NSE:METROPOLIS) Strong Returns On Capital Mean

I Ran A Stock Scan For Earnings Growth And Metropolis Healthcare (NSE:METROPOLIS) Passed With Ease

May 28
I Ran A Stock Scan For Earnings Growth And Metropolis Healthcare (NSE:METROPOLIS) Passed With Ease

Metropolis Healthcare (NSE:METROPOLIS) Is Aiming To Keep Up Its Impressive Returns

Mar 29
Metropolis Healthcare (NSE:METROPOLIS) Is Aiming To Keep Up Its Impressive Returns

Does Metropolis Healthcare's (NSE:METROPOLIS) Share Price Gain of 15% Match Its Business Performance?

Mar 11
Does Metropolis Healthcare's (NSE:METROPOLIS) Share Price Gain of 15% Match Its Business Performance?

Trade Alert: The Chief Executive Officer Of Metropolis Healthcare Limited (NSE:METROPOLIS), Vijender Singh, Has Sold Some Shares Recently

Feb 24
Trade Alert: The Chief Executive Officer Of Metropolis Healthcare Limited (NSE:METROPOLIS), Vijender Singh, Has Sold Some Shares Recently

Metropolis Healthcare Limited (NSE:METROPOLIS) Passed Our Checks, And It's About To Pay A ₹8.00 Dividend

Feb 12
Metropolis Healthcare Limited (NSE:METROPOLIS) Passed Our Checks, And It's About To Pay A ₹8.00 Dividend

Metropolis Healthcare Limited's (NSE:METROPOLIS) 0.4% Dividend Yield Looks Pretty Interesting

Feb 09
Metropolis Healthcare Limited's (NSE:METROPOLIS) 0.4% Dividend Yield Looks Pretty Interesting

Is Metropolis Healthcare Limited (NSE:METROPOLIS) Popular Amongst Insiders?

Jan 25
Is Metropolis Healthcare Limited (NSE:METROPOLIS) Popular Amongst Insiders?

Is Metropolis Healthcare Limited's (NSE:METROPOLIS) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Jan 10
Is Metropolis Healthcare Limited's (NSE:METROPOLIS) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Surendran Chemmenkotil im Vergleich zu den Einnahmen von Metropolis Healthcare verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Mar 31 2024n/an/a

₹1b

Dec 31 2023n/an/a

₹1b

Sep 30 2023n/an/a

₹1b

Jun 30 2023n/an/a

₹1b

Mar 31 2023₹52m₹13m

₹1b

Vergütung im Vergleich zum Markt: SurendranDie Gesamtvergütung ($USD629.81K) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt Indian ($USD435.24K).

Entschädigung vs. Einkommen: Unzureichende Daten, um die Vergütung von Surendran mit der Unternehmensleistung zu vergleichen.


Geschäftsführer

Surendran Chemmenkotil

1.4yrs

Amtszeit

₹52,318,552

Vergütung

Mr. Surendran Chemmenkotil is Chief Executive Officer of Metropolis Healthcare Limited from January 2, 2023. He is a seasoned leader with rich and diverse experience across consumer facing companies such a...


Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Ameera Shah
Chairperson16.1yrs₹52.40m0.35%
₹ 364.1m
Surendran Chemmenkotil
Chief Executive Officer1.4yrs₹52.32mkeine Daten
Sushil Shah
Founder & Chairman Emeritusno data₹18.00m18.68%
₹ 19.2b
Rakesh Agarwal
Chief Financial Officer4.6yrs₹13.83mkeine Daten
Nilesh Shah
Group President and Chief of Science & Innovationno datakeine Datenkeine Daten
Kannan Alangadan
Chief Operating Officer – Operationsno datakeine Datenkeine Daten
Kirti Chadha
Chief Scientific Officer & Group CSR Headno datakeine Datenkeine Daten
Kamlesh Kulkarni
Head of Legal & Secretarial and Compliance Officerless than a yearkeine Datenkeine Daten
Jeyasingh Balakrishnan
Head of Public Relations & Corporate Communications2.8yrskeine Datenkeine Daten
Mohan Menon
Chief Marketing Officerless than a yearkeine Datenkeine Daten
Ishita Medhekar
Chief People Officer4.4yrskeine Datenkeine Daten
H. Ravikumar
Managing Director of RV Metropolisno datakeine Datenkeine Daten

1.4yrs

Durchschnittliche Betriebszugehörigkeit

Erfahrenes Management: METROPOLISDas Führungsteam des Unternehmens gilt nicht als erfahren (1.3 Jahre durchschnittliche Betriebszugehörigkeit), was auf ein neues Team schließen lässt.


Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Ameera Shah
Chairperson16.1yrs₹52.40m0.35%
₹ 364.1m
Sushil Shah
Founder & Chairman Emeritus18.8yrs₹18.00m18.68%
₹ 19.2b
Anita Ramachandran
Non-Executive Independent Director4.1yrs₹1.15mkeine Daten
Sanjay Bhatnagar
Non-Executive Independent Director5.8yrs₹765.00kkeine Daten
Vivek Gambhir
Non-Executive Independent Director5.8yrs₹1.19m0.00028%
₹ 287.2k
Hemant Sachdev
Non-Executive Independent Director3.1yrskeine Datenkeine Daten
Subramanian Ranganathan
Independent Directorless than a yearkeine Datenkeine Daten
Aparna Rajadhyaksha
Additional Non Executive Non-Independent Directorless than a yearkeine Datenkeine Daten

4.9yrs

Durchschnittliche Betriebszugehörigkeit

59yo

Durchschnittliches Alter

Erfahrener Vorstand: METROPOLISDie Vorstandsmitglieder gelten als erfahren (5.7 Jahre durchschnittliche Amtszeit).